Cormedix Inc (CRMD)

Jan 7, 2025, 7:30 AM EST - 10 days ago

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

Dec 19, 2024, 8:30 AM EST - 4 weeks ago

CorMedix Inc. Added to Nasdaq Biotechnology Index

Nov 26, 2024, 8:30 AM EST - 7 weeks ago

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

Nov 8, 2024, 8:00 AM EST - 2 months ago

Stock Picks From Seeking Alpha's October 2024 New Analysts

ACGL AMCX AMPS APOG AVRE BHP BILL

Nov 4, 2024, 8:30 AM EST - 2 months ago

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

Oct 30, 2024, 12:32 PM EDT - 2 months ago

CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:30 AM EDT - 2 months ago

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

Oct 28, 2024, 1:33 PM EDT - 2 months ago

CorMedix 2.0: New Leadership, New Approval, New Focus

Oct 25, 2024, 2:30 PM EDT - 3 months ago

Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital +

Oct 24, 2024, 8:30 AM EDT - 3 months ago

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

Oct 23, 2024, 8:30 AM EDT - 3 months ago

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

Sep 13, 2024, 8:30 AM EDT - 4 months ago

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

Sep 9, 2024, 10:52 AM EDT - 4 months ago

CorMedix Inc. Announces New Commercial Agreement

Aug 14, 2024, 2:08 PM EDT - 5 months ago

CorMedix Inc. (CRMD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:30 AM EDT - 5 months ago

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

Aug 7, 2024, 8:30 AM EDT - 5 months ago

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

Jul 3, 2024, 8:00 AM EDT - 7 months ago

CorMedix Inc. Announces Outpatient Availability of DefenCath

Jun 6, 2024, 8:30 AM EDT - 8 months ago

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

May 28, 2024, 8:30 AM EDT - 8 months ago

CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider

May 11, 2024, 5:48 PM EDT - 8 months ago

CorMedix Inc. (CRMD) Q1 2024 Earnings Call Transcript

May 10, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

May 9, 2024, 7:30 AM EDT - 9 months ago

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

May 6, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

Apr 19, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

Apr 15, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)

Apr 11, 2024, 8:30 AM EDT - 10 months ago

CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference

Apr 8, 2024, 8:30 AM EDT - 10 months ago

CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC

Mar 12, 2024, 11:17 AM EDT - 11 months ago

CorMedix (CRMD) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 7:30 AM EDT - 11 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 6, 2024, 8:30 AM EST - 11 months ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024

Jan 30, 2024, 8:30 AM EST - 1 year ago

CorMedix Inc. Announces Commercial and Reimbursement Updates

Jan 8, 2024, 8:30 AM EST - 1 year ago

CorMedix Inc. Announces Commercial and Operational Updates

Dec 15, 2023, 8:30 AM EST - 1 year ago

CorMedix Inc. Announces Appointment of Chief Legal Officer

Dec 4, 2023, 8:30 AM EST - 1 year ago

CorMedix Inc. Announces Partnership With The Leapfrog Group

Nov 15, 2023, 12:57 PM EST - 1 year ago

CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients

Nov 15, 2023, 10:11 AM EST - 1 year ago

U.S. FDA approves CorMedix's antimicrobial drug

Nov 14, 2023, 9:55 PM EST - 1 year ago

CorMedix Inc. (CRMD) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 4:05 PM EST - 1 year ago

CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update

Nov 2, 2023, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023

Oct 11, 2023, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference

Sep 26, 2023, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference

Sep 8, 2023, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology

Sep 6, 2023, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference

Aug 30, 2023, 8:00 AM EDT - 1 year ago

CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath

Aug 8, 2023, 12:57 PM EDT - 1 year ago

CorMedix Inc. (CRMD) Q2 2023 Earnings Call Transcript

Aug 8, 2023, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update

Jun 28, 2023, 10:57 PM EDT - 1 year ago

CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded Warrants

Jun 28, 2023, 4:07 PM EDT - 1 year ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Jun 21, 2023, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath

Jun 15, 2023, 8:30 AM EDT - 1 year ago

Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream Infections